PH23847A - Polypeptide - Google Patents

Polypeptide

Info

Publication number
PH23847A
PH23847A PH33004A PH33004A PH23847A PH 23847 A PH23847 A PH 23847A PH 33004 A PH33004 A PH 33004A PH 33004 A PH33004 A PH 33004A PH 23847 A PH23847 A PH 23847A
Authority
PH
Philippines
Prior art keywords
same
polypeptide
novel polypeptide
analgesic
chem
Prior art date
Application number
PH33004A
Other languages
English (en)
Inventor
Hiroshi Yoshino
Shinro Tachibana
Yutaka Tsuchiya
Takeru Kaneko
Takahiro Nakazawa
Masuhiro Ikeda
Shin Araki
Yoshihiro Arakawa
Kiyomi Tamatsu
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of PH23847A publication Critical patent/PH23847A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/675—Beta-endorphins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PH33004A 1984-11-09 1985-11-04 Polypeptide PH23847A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP59236076A JPH0680079B2 (ja) 1984-11-09 1984-11-09 ポリペプチド

Publications (1)

Publication Number Publication Date
PH23847A true PH23847A (en) 1989-11-23

Family

ID=16995360

Family Applications (1)

Application Number Title Priority Date Filing Date
PH33004A PH23847A (en) 1984-11-09 1985-11-04 Polypeptide

Country Status (21)

Country Link
US (1) US4707468A (index.php)
EP (2) EP0614913A3 (index.php)
JP (1) JPH0680079B2 (index.php)
KR (1) KR880000765B1 (index.php)
CN (1) CN1029684C (index.php)
AT (1) ATE135712T1 (index.php)
AU (1) AU588837B2 (index.php)
CA (1) CA1267997A (index.php)
DE (1) DE3588095T2 (index.php)
DK (1) DK171300B1 (index.php)
ES (1) ES8800272A1 (index.php)
FI (1) FI92935C (index.php)
GR (1) GR852689B (index.php)
HU (1) HU203563B (index.php)
IL (1) IL76924A (index.php)
NO (1) NO169347C (index.php)
NZ (1) NZ214122A (index.php)
PH (1) PH23847A (index.php)
PT (1) PT81441B (index.php)
SU (1) SU1433415A3 (index.php)
ZA (1) ZA858456B (index.php)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673376A1 (fr) * 1991-03-01 1992-09-04 Lefesvre Andre Composition pharmaceutique pour le traitement des tumeurs de kaposi.
US5817628A (en) * 1992-12-02 1998-10-06 The Rockefeller University Dynorphin a suppression of natural killer cell activity
SE9401596D0 (sv) * 1994-05-06 1994-05-06 Astra Ab New compounds
JP3385147B2 (ja) * 1996-01-31 2003-03-10 ユニ・チャーム株式会社 男性用尿とり袋
WO1997049422A1 (en) * 1996-06-24 1997-12-31 The Rockefeller University Method of using ligands of the kappa opioid receptor
AU757658B2 (en) * 1998-03-09 2003-02-27 Zealand Pharma A/S Pharmacologically active peptide conjugates having a reduced tendency towards enzymatic hydrolysis
US6232287B1 (en) * 1998-03-13 2001-05-15 The Burnham Institute Molecules that home to various selected organs or tissues
IL137820A (en) * 2000-08-10 2009-06-15 S I S Shulov Inst For Science Pharmaceutical composition for topical administration comprising an analgesic peptide
EP2210598B1 (en) * 2000-08-25 2013-09-18 Research Corporation Technologies, Inc. Anticonvulsant amino acids for the treatment of pain
PT1243262E (pt) * 2001-03-20 2006-10-31 Sanol Arznei Schwarz Gmbh Nova utilizacao de uma classe de compostos peptideos para o tratamento da dor inflamatoria nao neuropatica
PT1243263E (pt) * 2001-03-21 2003-03-31 Sanol Arznei Schwarz Gmbh Nova utilizacao de uma classe peptidica de composto para o tratamento de alodinia ou de outros tipos diferentes de dor cronica ou fantasma
US7491702B2 (en) * 2001-04-18 2009-02-17 The Open University Polypeptides related to amyloid precursor protein, pharmaceutical compositions thereof, and methods of treatment using the same
US7622446B2 (en) * 2001-04-18 2009-11-24 The Open University Polypeptides, derivatives and uses thereof
NZ550482A (en) 2004-04-16 2010-08-27 Sanol Arznei Schwarz Gmbh Use of peptidic compounds for the prophylaxis and treatment of chronic headache
KR20070045271A (ko) * 2004-08-27 2007-05-02 쉬바르츠파르마에이지 골암 통증, 화학요법- 및 뉴클레오시드- 유도 통증의치료를 위한 펩티드 화합물의 용도
US20070043120A1 (en) * 2005-08-18 2007-02-22 Bettina Beyreuther Therapeutic combination for painful medical conditions
US20070048372A1 (en) * 2005-08-18 2007-03-01 Srz Properties, Inc. Method for treating non-inflammatory osteoarthritic pain
EP1754476A1 (en) * 2005-08-18 2007-02-21 Schwarz Pharma Ag Lacosamide (SPM 927) for treating myalgia, e.g. fibromyalgia
GB2432586B (en) * 2005-11-25 2010-01-13 Univ Open Treatment of neurodegenerative disorders
BRPI0713594A2 (pt) * 2006-06-15 2012-10-30 Sanol Arznei Schwarz Gmbh composição farmacêutica com efeito anticonsulsivante sinérgico
WO2009039985A2 (en) * 2007-09-11 2009-04-02 Mondobiotech Laboratories Ag Therapeutic uses of urocortin ii
WO2009043464A2 (en) * 2007-09-11 2009-04-09 Mondobiotech Laboratories Ag Astressin and beta- endorphin for use as therapeutic agents
TW201920234A (zh) 2017-09-11 2019-06-01 美商領導醫療有限公司 類鴉片促效劑肽及其用途
CA3188556A1 (en) * 2020-07-01 2022-01-06 PreveCeutical Medical Inc. Peptides and uses thereof
RU2760133C1 (ru) * 2021-04-22 2021-11-22 Федеральное государственное бюджетное учреждение науки "Научный центр биомедицинских технологий Федерального медико-биологического агентства". Амиды гептапептида для лечения HMGB1-зависимых заболеваний

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254106A (en) * 1976-01-26 1981-03-03 Burroughs Wellcome Co. Biologically active amides
FI70228C (fi) * 1976-01-26 1986-09-15 Wellcome Found Foerfarande foer framstaellning av en enkefalin-analog-peptid
US4123523A (en) * 1976-06-21 1978-10-31 Imperial Chemical Industries Limited Analgesic and sedative polypeptides
US4371463A (en) * 1977-02-17 1983-02-01 The United States Of America As Represented By The Department Of Health And Human Services Enzyme-resistant opiate pentapeptides
US4081434A (en) * 1977-03-11 1978-03-28 Hoffmann-La Roche Inc. Novel analogs of β-endorphin
US4127533A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel octapeptides, intermediates therefor, and compositions and methods employing said octapeptides
US4139504A (en) * 1977-06-16 1979-02-13 Coy David Howard Novel nonapeptides, intermediates therefor, and compositions and methods employing said nonapeptides
GB1604850A (en) * 1977-11-24 1981-12-16 Wellcome Found Biologically active peptides
US4148786A (en) * 1978-06-26 1979-04-10 American Home Products Corporation Analgesic polypeptide
US4178284A (en) * 1978-12-11 1979-12-11 American Home Products Corporation Octapeptides
DE2936099A1 (de) * 1979-09-06 1981-04-02 Victor Dipl.- Chem. 8000 München Brantl Pharmakologisch aktive peptide
EP0044451B1 (en) * 1980-07-17 1984-04-18 Sandoz Ag Novel pentapeptides, processes for their production, pharmaceutical compositions comprising said pentapeptides and their use
JPS57134451A (en) * 1981-02-13 1982-08-19 Suntory Ltd Peptide opioide
DE3274798D1 (en) * 1981-10-05 1987-02-05 Nicholas P Plotnikoff Process for using endorphins as antitumour agents
US4462941A (en) * 1982-06-10 1984-07-31 The Regents Of The University Of California Dynorphin amide analogs
JPS59141547A (ja) * 1983-02-01 1984-08-14 Eisai Co Ltd 鎮痛作用を有する新規ペプタイドおよび製法
US4518711A (en) * 1983-05-16 1985-05-21 Gibson-Stephens Institute Conformationally constrained cyclic enkephalin analogs with delta receptor specificity

Also Published As

Publication number Publication date
IL76924A0 (en) 1986-04-29
SU1433415A3 (ru) 1988-10-23
ZA858456B (en) 1987-07-29
DK513385D0 (da) 1985-11-07
EP0181001A2 (en) 1986-05-14
ATE135712T1 (de) 1996-04-15
HU203563B (en) 1991-08-28
GR852689B (index.php) 1986-02-21
PT81441B (pt) 1987-11-11
NO854435L (no) 1986-05-12
IL76924A (en) 1990-07-12
FI92935C (fi) 1995-01-25
FI854227L (fi) 1986-05-10
PT81441A (en) 1985-12-01
EP0181001A3 (en) 1989-04-19
AU588837B2 (en) 1989-09-28
HUT40145A (en) 1986-11-28
JPS61115097A (ja) 1986-06-02
NO169347C (no) 1992-06-10
ES548667A0 (es) 1987-10-16
FI92935B (fi) 1994-10-14
EP0181001B1 (en) 1996-03-20
DK513385A (da) 1986-05-10
AU4938985A (en) 1986-05-15
NO169347B (no) 1992-03-02
FI854227A0 (fi) 1985-10-28
EP0614913A2 (en) 1994-09-14
CN85109722A (zh) 1986-10-08
ES8800272A1 (es) 1987-10-16
DE3588095D1 (de) 1996-04-25
EP0614913A3 (en) 1997-06-04
KR860004081A (ko) 1986-06-16
US4707468A (en) 1987-11-17
DK171300B1 (da) 1996-08-26
JPH0680079B2 (ja) 1994-10-12
CA1267997A (en) 1990-04-17
DE3588095T2 (de) 1996-09-19
CN1029684C (zh) 1995-09-06
NZ214122A (en) 1988-08-30
KR880000765B1 (en) 1988-05-06

Similar Documents

Publication Publication Date Title
ZA858456B (en) Polypeptide
AU643489B2 (en) Antibacterial agents - II
EP0074130A3 (en) New imidazole compounds, process for the preparation thereof and pharmaceutical compositions containing them
HUT41025A (en) Process for preparing octahydro-indolizine derivatives and pharmaceutical compositions containing such compounds as active ingredients
AU3527484A (en) N-benzyl-n-phenyl-b-pyrrolidinyl-f-isobutoxy-propylamine
ZA872276B (en) Pharmaceutical compositions containing 5-phenyl-1,3-dioxoalkenyl compounds
AU562271B2 (en) Pharmaceutical composition of corazepam and diphenhydramine
EP0241292A3 (en) 4-substituted octahydroquinolizine analgesic compounds and octahydroquinolizinium intermediates
DE3469358D1 (en) Novel 3-(4'-aminobutylamino)-propylamino-bleomycin derivatives, a process for their preparation and their use as medicaments
GR850484B (index.php)
GR3019381T3 (en) 3-Anilino-2-hydroxycarbonyl-4-thiophen-acetic acids
GR3022259T3 (en) Tetrahydro-4-phenylimino-3-thiophen-acetic acids